Advertisement

Innovation

Link Ventures, a Boston-based venture capital fund, launched its third fund focusing on early-stage technology companies, including digital health companies, with $150 million to invest.

Advertisement

The first drugs designed with the help of artificial intelligence are being tested in clinical trials, MIT Technology Review reported Feb. 15. 

Synchron, a brain-computer interface company backed by the venture capital arms of Amazon founder Jeff Bezos and Microsoft founder Bill Gates, is halfway through a trial designed to show its brain implant is safe for humans, CNBC reported Feb. 18.

Advertisement